Compared with IDH-mutant tumors, IDH-WT GBM tumors harbor microglia with increased expression of reactive phenotype genes (e.g., CD14 and CD64) and more macrophages with increased expression of HLA-DR and MHC I/II genes (18). This evidence concerns the gene IDH1 and glioblastoma.